Skip to main content
Caplight Logo









Bonito Biosciences

Bonito Biosciences

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://www.bonitobio.com/

Company Overview

Bonito Biosciences is a biotechnology company developing a data foundation for programmable oligonucleotide delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Infrastructure

Keywords

drug delivery platformoligotherapeutic deliveryAI drug discoveryRNA deliveryAI biotechligand discoverycentral nervous system deliveryCNS deliverygenerative biologyoligotherapeuticsRNA therapeuticsdrug discovery platformencoded ligand librariesfunctional screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bonito Biosciences Comparables

Compare Bonito Biosciences with similar companies based on industry and business-model similarity.

Bonito Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gensaic
86%
Nosis Bio
85%
Vivatides Therapeutics
78%

Bonito Biosciences Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Richard Wagner

Chief Executive Officer And Founder

Founding Team

Bonito Biosciences Investors

Notable investors and investment history

Bonito Biosciences investors
InvestorRounds
Lightstone VenturesSeed
JAZZ Venture PartnersSeed
Anterra CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 203% MoM, reaching 4.5K.

  • Mar 1, 2026

    Monthly visitors grew 75% MoM, from 1K to 1.8K.

Bonito Biosciences Filings

Explore SEC and related filing metadata, where available.

Bonito Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bonito Biosciences's valuation, stock price, and market status.

Is Bonito Biosciences a public or private company?

Bonito Biosciences is a private company.

What is the current stock price of Bonito Biosciences?

Bonito Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Bonito Biosciences worth (valuation)?

Valuation information for Bonito Biosciences is not publicly available.

Can I buy Bonito Biosciences stock?

Bonito Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bonito Biosciences's last funding round?

Funding round information for Bonito Biosciences is not publicly available.

Who are the main investors in Bonito Biosciences?

Investor information for Bonito Biosciences is not publicly disclosed.

Will Bonito Biosciences IPO soon?

No public IPO plans have been announced for Bonito Biosciences.

How can I track Bonito Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bonito Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range23
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?